Healthcare analysts discuss the evolving pipeline and the latest breakthrough in Lupus (relevant companies ALLO, IGMS, KYTX) on an Analyst/Industry conference call to be held on December 4 at 11 am.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALLO:
- Biotech Alert: Searches spiking for these stocks today
- Allogene Therapeutics presents data for ALLO-329 in autoimmune disease
- Allogene Therapeutics price target lowered to $9 from $11 at Piper Sandler
- Allogene Therapeutics Advances CAR T Therapies
- Allogene Therapeutics reports Q3 EPS (32c), consensus (33c)